OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PARP inhibitors combined with radiotherapy: are we ready?
Chen Sun, Alan Chu, Rui Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Chen Sun, Alan Chu, Rui Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Showing 17 citing articles:
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 8
Denys Bondar, Yevgen Karpichev
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1269-1269
Open Access | Times Cited: 8
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
Jordan Phillipps, George Nassief, Renee Morecroft, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Jordan Phillipps, George Nassief, Renee Morecroft, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Method for determining a Prostate Cancer LET Sensitivity Index (PCLSI) using tumour-specific DDR mutations for proton RBE
Mark Artz, Michael Vieceli, Jiyeon Park, et al.
Journal of Radiotherapy in Practice (2025) Vol. 24
Closed Access
Mark Artz, Michael Vieceli, Jiyeon Park, et al.
Journal of Radiotherapy in Practice (2025) Vol. 24
Closed Access
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
Aging (2025)
Open Access
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
Aging (2025)
Open Access
Immunological Effects of Proton Radiotherapy: New Opportunities and Challenges in Cancer Therapy
Anhang Zhang, L. T. Fan, Qi Liu, et al.
Cancer Innovation (2025) Vol. 4, Iss. 2
Open Access
Anhang Zhang, L. T. Fan, Qi Liu, et al.
Cancer Innovation (2025) Vol. 4, Iss. 2
Open Access
Exploring cell death pathways in oral cancer: mechanisms, therapeutic strategies, and future perspectives
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Advances with radiopharmaceutical therapy in cancer
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Unlocking the power of imidazoquinolines: recent advances in anticancer and immunotherapeutic strategies
Ranjini Jenifer R, Badruzzaman Choudhury, Mohammed Mujahid Alam, et al.
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
Ranjini Jenifer R, Badruzzaman Choudhury, Mohammed Mujahid Alam, et al.
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review
Clémentine Fulbert, Tristan Doussineau, Léna Carmès, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 519-519
Open Access
Clémentine Fulbert, Tristan Doussineau, Léna Carmès, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 519-519
Open Access
Role of Oxidative Stress Signaling, Nrf2, on Survival and Stemness of Human Adipose-Derived Stem Cells Exposed to X-rays, Protons and Carbon Ions
Mira Hammad, Rima Salma, Jacques Balosso, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1035-1035
Open Access | Times Cited: 2
Mira Hammad, Rima Salma, Jacques Balosso, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1035-1035
Open Access | Times Cited: 2
PARP inhibitors in prostate cancer: clinical applications
Hamidreza Saeidi, Mohsen Sarafbidabad
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Hamidreza Saeidi, Mohsen Sarafbidabad
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review
Hung‐Liang Pai, Chin-Yin Liu, Ming‐Hsin Yeh
Medicina (2024) Vol. 60, Iss. 7, pp. 1092-1092
Open Access | Times Cited: 1
Hung‐Liang Pai, Chin-Yin Liu, Ming‐Hsin Yeh
Medicina (2024) Vol. 60, Iss. 7, pp. 1092-1092
Open Access | Times Cited: 1
Impaired PARylation Turnover in Radiation- Damaged Tissue
Felicitas Mayer, Ivonne Kemnitz, Peter Geyer, et al.
(2024)
Open Access | Times Cited: 1
Felicitas Mayer, Ivonne Kemnitz, Peter Geyer, et al.
(2024)
Open Access | Times Cited: 1
Strahlentherapie und molekular zielgerichtete Therapie – alles gezielt?
Sören Schnellhardt, Markus Hecht
Deleted Journal (2024) Vol. 30, Iss. 10, pp. 938-944
Closed Access
Sören Schnellhardt, Markus Hecht
Deleted Journal (2024) Vol. 30, Iss. 10, pp. 938-944
Closed Access
Variability in Radiotherapy Outcomes Across Cancer Types: A Comparative Study of Glioblastoma Multiforme and Low-Grade Gliomas
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
